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Abstract. Meningococcal meningitidis is a life-
threatening disease. In Europe and the United States
the majority of cases are caused by virulent menin-
gococcal strains belonging to serogroup B. Presently
there is no effective vaccine against serogroup B
strains, as traditional vaccine antigens such as poly-
saccharide capsules are unusable as they lead to au-
toimmunity. The year 2000 saw the publication of the
complete genome of Neisseria meningitidis MC58, a
virulent serogroup B bacterium. Working in con-
junction with the sequencing project, researchers
endeavored to locate highly conserved membrane-
associated proteins that elicit an immune response. It
is hoped that these proteins will provide a basis for
novel vaccines against serogroup B strains. A number
of potential vaccine antigens have been located and
are presently in phase I clinical trials. Recently many
reports pertaining to the evidence of positive Dar-
winian selection in membrane proteins of pathogens
have been reported. This study utilized in silico
methods to test for evidence of historical positive
Darwinian selection in seven such vaccine candidates.
We found that two of these proteins show signatures
of adaptive evolution, while the remaining proteins
show evidence of strong purifying selection. This has
significant implications for the design of a vaccine
against serogroup B strains, as it has been shown that
vaccines that target epitopes that are under strong
purifying selection are better than those that target
variable epitopes.
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Introduction
Neisseria meningitidis is a gram-negative, encapsu-
lated b-proteobacterium that is naturally competent
for transformation with DNA. It only thrives in the
human host and is not known to colonize any other
animal or environmental niches. Meningococcal car-
riage is very much more common than disease.
Asymptomatic colonization of the nasopharynx is
common, reaching 10% or more of the population in
many countries. However for reasons still poorly
understood, certain strains can penetrate the mucosal
epithelium and gain access to the circulation system
(Grandi 2003). In individuals lacking humoral
immunity to meningococci, proliferation of the
organisms in the blood may lead to septicaemia,
characterized by circulatory collapse, multiple organ
failure, and coagulopathy, additionally some virulent
strains may also reach the subarachnoid compart-
ment and initiate meningitis (Nassif et al. 1999).
Meningococcal meningitis is a significant public
health problem and is responsible for deaths and
disability through epidemics in sub-Saharan Africa,
and many other sporadic cases worldwide (Tettelin
et al. 2000). Without prompt antibiotic treatment,
meningococcal infection is almost always fatal
(Nassif 2002), and even with prompt treatment death
and sequelae are common (Naess et al. 1994). Those
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most at risk from meningococcal infection include
persons in the 15–24 age group and children under
the age of 5. Annual incidence of meningococcal
disease varies from 0.5 to 10 per 100,000 persons, but
during epidemics the incidence rate can rise to above
400 per 100,000 persons. Presently five pathogenic
N. meningitidis serogroups (A, B, C, Y, and W135)
have been described based on capsular polysaccha-
ride typing (Gotschlich et al. 1969).
To date there has been some success in vaccine
design against four of the five pathogenic serogroups
(A, C, Y, and W135). These vaccines consist of
purified polysaccharide antigens, are highly effective
in adults and the high molecular polysaccharides used
in these vaccines are produced in the same manner as
first described by Gotschlich et al. (1969). There is
presently no effective vaccine against serogroup B,
however, as the capsular polysaccharide of this bac-
terium is identical to a widely distributed human
carbohydrate (polysialic acid), preventing the use of
this as a vaccine antigen for fear it may induce au-
toimmunity (Nassif 2002). Vaccine design against
strains of serogroup B is a priority as they cause the
majority of invasive disease in Europe (>50% of
cases) and the United States (>30% of cases).
The problems associated with developing a
meningococcal serogroup B vaccine has led
researchers to explore the possibility of targeting
membrane-exposed proteins. Administration of an
immunizing agent early in life should induce the
production of serum bactericidal antibodies, which
are the mark of resistance of meningococcal disease
(Goldschneider et al. 1969). Suitable antigens include
those that are conserved among a population, are
expressed on the surface of the bacteria, and also
induce the production of bactericidal antibodies
(Nassif 2002). Using these criteria, the complete
genome sequence of N. meningitidis B (strain MC58)
(Tettelin et al. 2000) was used to locate open reading
frames (ORFs) that potentially encode surface-ex-
posed or exported proteins (Pizza et al. 2000). From
the 570 candidate ORFs located they successfully
cloned and expressed 350 of these into Escherichia
coli. The resultant recombinant proteins were used to
immunize mice and the immune sera were tested for
bactericidal activity, as this correlates with protection
in humans (Pizza et al. 2000). Finally, from 85 pro-
teins that elicit bactericidal activity the suitability of
these proteins as candidate antigens for conferring
protection against heterologous meningococcal
strains was tested. The tests were carried out on 34
different N. meningitidis clinical strains isolated
worldwide and over many years. This process re-
sulted in the identification of seven proteins that
confer protection against both homologous and het-
erologous meningococcal strains. The sera against
these antigens are capable of killing all the menin-
gococcal strains so far utilized in the complement-
mediated bactericidal assay, thus making the antigens
particularly promising for vaccine formulations.
Presently phase 1 clinical studies are in progress to
establish the ability of these antigens to induce bac-
tericidal antibodies in humans (Grandi 2003). These
genes are highly conserved, which is an unusual
finding considering that in three decades of studies,
with one exception (Martin et al. 1997), only anti-
genically variable surface exposed proteins had been
described (Pizza et al. 2000). Furthermore, the fre-
quency of recombination of these genes is relatively
low (0.011 using the homoplasy test [Maynard-Smith
and Smith 1998]), a level of recombination that is
similar to that of Neisseria housekeeping genes
(Maynard-Smith and Smith 1998).
Recently a number of membrane-associated
meningococcal proteins (Andrews and Gojobori
2004; Smith et al. 1995) have been shown to be under
the influence of positive Darwinian selection (adap-
tive evolution). Adaptive evolution is a process that
encourages the retention of mutations that are ben-
eficial to an individual or population (Creevey and
Mclnerney 2002). In protein coding genes, positive
selection is thought to be an ephemeral event fre-
quently leading to the generation of novel protein
function (Kinsella et al. 2003). At the DNA level,
positive selection may be detected by comparing the
rate of nonsynonymous (amino acid altering) nucle-
otide substitutions per nonsynonymous site (dN) with
that of synonymous substitution per synonymous site
(dS). When dN/dS>1 positive selection is said to be
operating on the genes in question, alternatively when
dN/dS < 1 purifying selection is said to be operating.
Positive selection has been observed in membrane-
associated genes of several pathogens (Andrews and
Gojobori 2004; Bush et al. 1999; Fares et al. 2001;
Jiggins et al. 2002; Kinsella et al. 2003; Urwin et al.
2002; Yang 2000; Yang 2001; Zanotto et al. 1999)
and can be described as a host–parasite arms race
(Jiggins et al. 2002). As the membrane proteins of
pathogens are exposed to the host immune system, it
follows that they may be under the greatest selective
pressure for change. From mathematical modeling of
viral infection dynamics it has been suggested that
conserved epitopes are more appropriate as vaccine
targets than variable epitopes (Nowak et al. 1991).
Therefore, it would be helpful if we could predict
candidate epitopes computationally, as it should
accelerate the entire vaccine process. Observations
have linked the success and failure of present-day
vaccines to the presence/absence of positive selection.
For example, annual vaccines against influenza A
virus has to be developed due to its rapid antigenic
change; conversely, the extremely successful poliovi-
rus vaccine has been shown to be under strong neg-
ative selection (Suzuki 2004). These observations
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would lead us to conclude that candidate vaccine
targets should contain no positively selected sites, a
view that has been expressed by others (Suzuki 2004).
From a protein structure perspective, it is likely
that there are two categories of proteins, those that
are amenable to change and those that, for structural
reasons, cannot easily change. An ideal vaccine can-
didate should be in the second category and it should
be possible to determine from analyzing the evolu-
tionary history of a set of sequences if change via
positive selection is easy or difficult in those se-
quences. In this paper we test the hypothesis that the
seven gene families currently being considered as
potential vaccine candidates (Pizza et al. 2000) show
evidence of historical positive selection. The reason
for proposing this situation is that these proteins are
known to be expressed at high levels, are surface
exposed, and elicit a strong immune reaction during
infection. We discuss our findings in light of the
implications for vaccine design.
Materials and Methods
Sequence Data
Twenty-two N. meningitidis serogroup B strains, three serogroup A
strains, two serogroup C strains, one strain each of serogroups W,
X, Z, and Y, one strain of N. cinerea, one strain of N. lactamica,
and three strains of N. gonnorrhoeae were used in this analysis.
Seven gene families (putative vaccine targets) were examined. The
nomenclature of each family corresponds to the annotation of the
completely sequenced MC58 genome (Tettelin et al. 2000), There-
fore, we call these families by the names NMB0033, NMB0992,
NMB1162, NMB1220, NMB1946, NMB2001, and NMB2132. The
accession numbers for each of the genes is as follows: NMB0033
(AF226387–AF226417 and AF235143–AF235145), NMB0992
(AF226356–AF226386), NMB1162 (AF226542–AF226565 and
AF235157–AF235158), NMB1220 (AF226542–AF226572 and
AF235157–AF235159), NMB1946 (AF226480–AF226510 and
AF235151–AF235153), NMB2001 (AF226449–AF226479 and
AF235148–AF235150), and NMB2132 (AF226418–AF226448 and
AF235146–AF235147). See Pizza et al. (2000) for a complete list of
references.
Terminal stop codons were removed from all sequences. Any
nucleotide sequence that was found to be identical to another strain
was removed from the analysis. The nucleotide sequences were
translated into their amino acid equivalents and aligned using
CLUSTALW verl.82 (Thompson et al. 1994). Gaps created in the
amino acid alignment were transposed back to the nucleotide se-
quences to gain a codon-based alignment using the program Put-
gaps (http://bioinf.may.ie/software/putgaps). Codon alignments
were corrected for obvious alignment ambiguity using the align-
ment editor Se-Al 2.0a11 (http://evolve.zoo.ox.ac.uk/soft-
ware.html?id=seal). The average pairwise similarity for all gene
families was found to be greater than 95%.
Data Analysis
Phylogenies for all gene families were constructed using the maxi-
mum likelihood criterion in PAUP 4 (Swofford 1998), the optimal
model of sequence substitution was selected for by comparing the
likelihood scores using MODELTEST 3.04 (Posada and Crandall
1998).
Using the method of Gassly and Holmes (1997) as implemented
in PLATO 2.0, we searched for blocks of sequences that have
incongruent phylogentic topologies due to recombination. PLATO
locates spatial variation in an alignment that results in different
regions of the alignment supporting different phylogenies. Such
variation is indicative of recombination. PLATO utilizes the
maximum likelihood phylogenetic tree for a gene together with its
substitution model and calculates the likelihood of this hypothesis
along the alignment. The reasoning behind this step is that
recombination leads to apparent substitution rate heterogeneity
and can closely resemble the effects of molecular adaptation, thus
by excluding incongruent blocks we will lessen the possibility of
finding false positive results.
In the absence of tertiary structure data, the ConSeq (Berezin
et al. 2004) web server was used for the identification of biologically
important residues within all seven gene families. Functionally
important residues are often solvent accessible and evolutionary
conserved while structurally important residues are normally highly
conserved and found within the protein core. Ideally, vaccine tar-
gets should be from the former category, as they are accessible and
not likely to change. Using ConSeq we hope to locate such exposed
functionally important residues.
Analysis of Selection
The likelihood ratio test (LRT) approach of Yang et al. (2000) as
implemented in the PAML package 3.13 (Yang 1997) was used to
examine selection pressures acting on different amino acid positions
in the meningococcal gene families. Given that selective pressures
are likely to vary across different sites in a protein sequence, models
have been developed to incorporate heterogeneous selective pres-
sures at different sites (Yang et al. 2000). This approach evaluates
nested models of sequence evolution. Some models are more
parameter-rich extensions of other models, and when this is the
case, an LRT may be performed with twice the log-likelihood
difference being compared with a v2 distribution with the degrees of
freedom equal to the difference in the number of parameters. We
used three LRTs. The first compares a model that assumes one
dN:dS ratio (x hereafter called model M0) for all sites with a model
that assumes two site classes with independent D values estimated
from the data (hereafter called model M3; k = 2). The second
LRT compares a model that allows two site classes with values
fixed at 0 and 1 (hereafter called M1 [neutral]), with a model that
has an additional site class that allows x to be greater than unity
(hereafter called model M2 [selection]). The final LRT compares
M7, which has x b-distributed between 0 and 1 among 10 site
classes each of equal proportion, with a model that allows an
additional site class where x is freely estimated (hereafter called
model M8). The comparison of M7 vsM8 is the most powerful test
of positive selection (Anisimova et al. 2001).
The second major step identifies those codon sites under po-
sitive selection when the LRT suggests their presence. This is
achieved using the Bayes theorem to calculate the posterior
probabilities sites are from different x classes (Nielsen and Yang
1998). Positions with a high probability of coming from the class
with x > 1 are likely to be under positive selection (Swanson
et al. 2001).
Maximum likelihood models that allow for heterogeneity in the
dN/dS ratio among lineages were also tested. The simplest model is
the one-ratio model, M0. The most general model is the free-ratio
model, which assumes as many x parameters as the number of
branches in the tree; this is a parameter-rich model (Yang 1998).
Models that fit between these two extremes include the two-ratio
model and three-ratio models; these allow predefined lineages to
have a different x value from the rest of the tree (Yang 1998). All of
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these methods were utilized in an effort to detect if positive selec-
tion has acted along major lineages within the seven gene families.
Recent studies have shown that under certain conditions ML
methods can be sensitive to violations of assumptions made in
models that test for positive selection; these sensitivities under
certain conditions can result in false positives (Suzuki and Nei
2001a, 2004). To account for this, a maximum-parsimony (mp)
method that tests for adaptive evolution was applied. A sliding
window procedure that uses the model of Li (1993) as implemented
in SWAPSC (Fares 2004) was used. This method infers a statisti-
cally optimum codon-window size and slides it along the align-
ment. Each window step is then tested for the significance of
nonsynonymous substitutions to synonymous substitutions and the
nonsynonymous-to-synonymous rate ratio x; in this manner,
positively, neutrally, or negatively evolving sites can be located.
This method also has the ability to test for saturation of synony-
mous substitutions (Fares 2004); if any sites are highlighted, they
can be removed.
Results
Analysis of Recombination
The effects of recombination on methods that detect
positive selection have been documented (Anisimova
et al. 2003). In an effort to ensure that these pitfalls
do not affect the results reported, the method of
Grassly and Holmes (1997) was utilized to ensure
that no recombination had occurred within our
dataset. This method analyzes an alignment for se-
quence blocks within the alignment that deviate
significantly from a predefined topology (the ML
tree found earlier). No blocks within the vaccine
candidate genes were found to deviate significantly
from the imposed phylogenies. Saturation of syn-
onymous sites is also an important issue when trying
to detect adaptive evolution events by the criterion
that dN/dS is greater than 1, as saturation can lead
to the underestimation of dS and an inflation of the
dN/dS ratio. The moving window program SWAPSC
(Fares 2004) was used in an effort to test for satu-
ration of synonymous sites. The vaccine candidate
genes were shown not to contain saturated synony-
mous sites, and for all seven gene families more than
95% of sites show strong evidence of strong puri-
fying selection.
Maximum Likelihood Analysis
Five of the seven vaccine candidate genes (NMB0033,
NMB1162, NMB1220, NMB1946, and NMB2001)
did not exhibit strong evidence of positive selection
(results not shown). Gene families were only placed
into the category of undergoing positive selection if
all three LRTs performed were significant. Analysis
of the selective pressures acting on the remaining two
families (NMB0992 and NMB2132) provided strong
evidence for positive selection (Tables 1 and 2). The
three LRTs for the NMB0992 data indicated that
there was strong evidence for positive selection at
some sites. All three LRTs performed were highly
significant (Table 1). M2 indicated that approxi-
mately 9% of sites had an x value of 3.95. For both
M3 and M8 approximately 11% of sites fell into a
strong positively selected class (x = 3.67). The pos-
itively selected codons identified by Bayesian poster-
ior probability were identical for M3 and M8. A
Table 1. ML analysis of NMB0992 using a variety of models
Model
Estimates of
parameters InL 2DlnL Positively selected codons
M0 (one ratio) x1 = 0.3868 )3396.06 None
M1 (neutral) p1 = 0.81, x1 = 0.00 )3326.86 Not allowed
p2 = 0.18, x2 = 1.00
M2 (selection) p1 = 0.87, x1 = 0.00
p2 = 0.02, x2 = 1.00
p3 = 0.09, x3 = 3.95
)3298.77 (M1 vs M2) 56
p < 0.0005
18, 35, 44, 50, 62, 64, 65 67, 78, 83,
102, 149, 176 278 373, 417, 472
M3 (discrete k = 2) p1 = 0.88, x1 = 0.00
p2 = 0.11, x2 = 3.67
)3298.84 (M0 vs M3) 194
p < 0.0005
11, 18, 35, 44, 50, 51,59, 61, 62, 64, 65,
67, 70, 74, 78, 83, 94, 102, 120,135, 137,
139, 143, 149, 176, 200, 202, 240, 254, 261,
278, 338, 351, 372, 373, 374, 382, 383, 417,
426, 439, 454, 472, 476, 491
M7 (b) p = 0.00130 )3327.02 Not allowed
q = 0.00455
M8 (b & x) p = 0.001, q = 1.81
p2 = 0.11, x1 = 3.67
)3298.84 (M7 vs M8) 56
p < 0.0005
11, 18, 35, 44, 50, 51,59, 61, 62, 64, 65, 67,70,74,
78, 83, 94, 102, 120,135,137, 139, 143, 149, 176,
200, 202, 240, 254, 261, 278, 338, 351, 372, 373,
374, 382, 383, 417, 426, 439, 454, 472, 476, 491
Note. p1, p2, and p3 refer to the proportion of sites in categories 1, 2, and 3, respectively. x refers to the dN/dS ratios in these categories of
sites. p and q are b estimates. Models M1 and M7 do not allow positively selected sites. The degrees of freedom for all likelihood ratio tests is
2. Positively selected codons in boldface represent the codons that are found by both the ML and the MP method as being under the
influence of positive Darwinian selection. For the ML analysis, only sites with a Bayesian probability greater than 95% are considered
significant, while a 95% confidence level was also assigned to the MP analysis.
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smaller number was suggested by M2, but these were
subsequently found to be a subset of those predicted
by M3 and M8. The LRT analysis of site-specific
variable selective pressures acting on NMB2132 again
provided support for hypotheses of adaptive evolu-
tion (Table 2). M0 estimated an average x value of
0.579. Again, using models that allow for variable x
values across sites, all three LRTs are highly signifi-
cant (p< 0.0005) and all three models find more than
9% (9.6, 30, and 10% for models M2, M3, and M8,
respectively) of sites to have an x value greater than 1
(3.97, 2.13, and 3.66). Bayesian posterior prob-
abilities indicate that the same 16 codons can be as-
signed with confidence (p> 0.95) to this class of sites
with a high x value for M3 and M8 while a smaller
number (13) are found for M2. These 13 sites overlap
with those found by the other two models.
In order to test the hypothesis that one or more
lineages are responsible for the finding of positive
selection or to identify lineages where positive
selection is stronger, likelihood models that allow
for different dN/dS ratios among evolutionary lin-
eages (Yang 1998) were used. In all cases none of
the LRTs performed allowed for positive selection
on any one lineage exclusively (results not shown).
This indicates that the results from the first set of
LRTs are the result of constant selection on specific
sites across all lineages and not focused on any
particular lineage.
Parsimony Analysis
A number of sites inferred to be under the influence
of positive Darwinian selection using the ML method
were not inferred using the parsimony sliding window
approach (Tables 1 and 2). The parsimony method
used in this analysis does not consider sites where dS
is equal to 0 as having undergone positive selection
even if the dN ratio is greater than 0. The ML
methods identify situations such as this as positively
selected events; therefore, the parsimony method is a
more conservative approach. This is the reason why
complete agreement between both methods is not
observed. In this study, we treat these sites as being
under the influence of positive selection. For
NMB0992 the sites inferred to be under positive
Darwinian selection have an average x value of 3.95.
An average x value of 3.12 was found for NMB2132.
The ML and MP methods that can detect positive
selection are generally in good agreement with one
another. Both methods inferred nearly the same set of
codons as having undergone positive Darwinian
selection for NMB213, and also for NMB0992 but to
a lesser extent (Tables 1 and 2).
Functionally Important Residues
A large number of functionally important residues
were predicted for both NMB0992 and NMB2132 by
ConSeq (Figs. 1 and 2). Obviously, the sites that have
been shown to be evolving under positive Darwinian
selection do not fit into this category, as there must be
a degree of variability at such a site before it can be
inferred to have undergone positive selection. The
positively evolving sites inferred by the ML method
are nearly all exposed (i.e., are not coiled into the
centre of the protein) and therefore most probably
interact with the host immune system. It is not par-
ticularly surprising that all codons identified as being
subject to positive selection encode amino acid acids
exposed on the protein surface, as not only are these
potentially subject to immune surveillance but also
they are likely to be structurally less constrained.
Table 2. Results of the ML analysis of NMB213z using a variety of models
Model Estimates of parameters lnL 2DlnL Positively selected codons
M0 (one ratio) x = 0.57 )6827.19 None
M1 (neutral) p1 = 0.58, x1 = 0.00 )6609.20 Not allowed
p2 = 0.42, x2 = 1.00
M2 (selection) p1 = 0.56, x1 = 0.00
p2 = 0.33, x2=1.00
)6552.92 (M1 vs M2) 435
p < 0.0005
217, 222, 224, 260, 264, 268, 276, 284, 290,
293, 305, 309, 311
p3 = 0.093 x3 = 3.97
M3 (discrete k = 2) p1 =0.70, x1 = 0.07
p2 = 0.30, x2 = 2.13
)6570.05 (M0 vs M3) 514
p < 0.0005
193, 217, 222, 224, 260, 264, 268, 276,
284, 289, 290, 292, 293, 305, 309, 311
M7(b) p = 0.018, q = 0.035 )6612.12 Not allowed
M8 (b & D) p = 0.02, q = 0.03
p1 = 0.11, x1 = 3.66
)6552.80 (M7 vs M8) 118
p < 0.0005
193, 217, 222, 224, 260, 264, 268, 276, 284,
289, 290, 292, 293, 305, 309, 311
Note. p1, p2, and p3 refer to the proportion of sites in categories 1, 2, and 3, respectively. D refers to the dN/dS ratios in these categories of
sites. p and q are b estimates. Models M1 and M7 do not allow positively selected sites. The degrees of freedom for all likelihood ratio tests is
2. Positively selected codons that are boldface and underlined represent the codons that are found by both the ML and the AMP method to
be under the influence of positive Darwinian selection. For the ML analysis only sites with a Bayesian probability greater than 95% are
considered significant, while a 95% confidence level was also assigned to the MP analysis.
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Discussion
The development of a vaccine against heterologous
N. meningitidis B strains is an ongoing process. De-
spite more than 20 years of research (Bjune et al.
1991; Frasch 1989; Sierra et al. 1991), vaccines to
protect against heterologous strains have yet to be
developed. Candidate vaccine designs including the
purification of the polysaccharide capsule are not an
option, as this may lead to autoimmunity.
Researchers are instead trying to locate highly con-
served membrane proteins that elicit a host immune
response. This analysis has found that two such
vaccine candidates display evidence of positive
selection. This finding may have implications for
vaccine design, as a protein that has exhibited an
ability to undergo selection in the past may do so
again. While we can only speculate, it is plausible that
further change at important antigen binding sites may
make any vaccines developed from these proteins
obsolete.
In this analysis, LRTs were used to model variable
selective pressures across sites and lineages for a
variety of vaccine candidates that are currently being
tested. Recently concerns have been raised regarding
the frequent false-positive results inferred using this
ML approach (Suzuki and Nei 2001b, 2004). In an
effort to add further validity to the ML results, a
parsimony analysis was also performed. According to
the ML analysis for selection within NMB2132, 16
sites are under the influence of adaptive evolution; the
parsimony method infers 15 of these sites also. There
were some discrepancies between the two methods
when NMB0992 was analyzed, as the ML method
inferred 45 sites, compared to the parsimony method,
which only inferred 5 of these sites. Therefore we
conclude that there is excellent evidence that 15 sites
within NMB2132 have undergone positive selection,
while there is corroborated evidence to suggest that at
least five sites within NMB0992 have also undergone
an adaptive event. Furthermore, the majority of these
sites are found within exposed regions and therefore
are likely to be in direct contact with host immune
responses.
High levels of recombination can affect ML anal-
ysis as can saturation of synonymous sites
(Anisimova et al. 2003). These concerns were care-
fully considered, yet in all seven gene families exam-
ined no signatures of major recombination events or
saturation of synonymous sites were observed. Pre-
viously these seven proteins have been shown to have
extremely low levels of recombination (Pizza et al.
Fig. 1. ConSeq predictions of structure for
NMB0992 demonstrated on AF226356, using all
homologous genes within this family. The sequence
of the query protein is displayed on the first row.
The second row lists the predicted burial status of
the site (i.e., b, buried, versus e, exposed). The
third row indicates residues predicted to be
structurally and functionally important: s and f,
respectively. Sites inferred as evolving under the
influence of positive selection are in boldface and
underlined; the majority of such sites are in exposed
regions of the protein.
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2000). Too few sequences can also affect the power of
the LRT, it has been suggested that a minimum of six
sequences is required for the results of such an ML
analysis to be valid (Anisimova et al. 2003). In all
seven datasets there was a minimum of 20 sequences;
therefore these concerns are not applicable to these
results.
Previous vaccine studies have concluded that
vaccines targeted against epitopes which consist of
negatively selected sites protect more efficiently than
those directed against epitopes which contain posi-
tively selected sites (Suzuki 2004). Following an
examination of the sites that have undergone positive
selection within the HIV genome, it has been sug-
gested that negatively selected sites could be used to
design a multiepitope vaccine directed against regions
of the virus that are unable to mutate and escape
immune recognition (de Oliveira et al. 2004). Using
this logic we suggest that of the seven Neisseria vac-
cine candidates analyzed here, careful examination
needs to be given to those that exhibit evidence of
positive selection. Among a suite of seven proteins
that are known to be highly expressed, known to be
surface exposed, and known to be capable of eliciting
a strong bactericidal immune response, two showed
evidence of having undergone positive selection. The
other five proteins do not display any historical evi-
dence of positive selection for change. The fact that
evidence of positive selection was found in some of
these proteins is not particularly surprising, given
that other membrane proteins have been shown to
evolve positively (Andrews and Gojobori 2004;
Jiggins et al. 2002; Smith et al. 1995). Intuitively we
would expect these proteins to be under the greatest
pressure for change in an effort to remain ahead of
host immune responses in the host–pathogen ‘‘arms
race.’’ What are the implications of this kind of
analysis? At this current moment in time, all these
proteins still elicit a bactericidal immune response.
However, if vaccines target epitopes that contain
positively selected sites such as those found in
NMB0992 and NMB2132, it is feasible that future
amino acid altering substitutions at these sites may
render such vaccines obsolete. From this analysis, we
would suggest that this kind of event is much more
likely in those proteins that have historically shown
an ability to evolve under positive selection than in
those proteins where positive selection has not been a
feature. We therefore propose that an analysis of
historical adaptive evolution seems to be a sensible
precautionary measure prior to the expensive process
of developing a vaccine. We suggest that the
Fig. 2. ConSeq predictions of structure for
NMB2132 demonstrated on AF226419, using all
homologous genes within this family. The sequence
of the query protein is displayed on the first row.
The second row lists the predicted burial status of
the site (i.e., b, buried, versus e, exposed). The third
row indicates residues predicted to be structurally
and functionally important: s and f, respectively.
Sites inferred as evolving under the influence of
positive selection are in boldface and underlined:
the majority of such sites are in exposed regions of
the protein.
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remaining five vaccine targets are ideal vaccine can-
didates due to the absence of positive Darwinian
selection, and any vaccines developed against
NMB0992 and NMB2132 should avoid targeting the
regions we have inferred to be under the influence of
positive selection.
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